Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine Plus Docetaxel in Non-Small-Cell Lung Cancer Patients
PLoS ONE - United States
doi 10.1371/journal.pone.0003695
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 11, 2008
Authors
Publisher
Public Library of Science (PLoS)